Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in all-Seattle deal

Silene CEO Dr. Alex Jiao. (NanoSurface Photo)

NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance of stem cells in drug development.

With the acquisition, NanoSurface is hoping to solve an essential problem in medicine, which is

This post was originally published on this site


Check out
%d bloggers like this: